| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8245312 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 6 Pages |
Abstract
Conclusion: Because of potential dosimetric effects of the Magna-Site, it is preferable to treat PMRT patients with permanent implants. However, it is not unreasonable to treat with a TE because the volume of tissue affected by attenuation from the Magna-Site is small. In this scenario, we recommend using 15 MV photons with compensating bolus.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shari M.D., Kathryn M.D., Ã
se Ph.D., Thomas J. Ph.D., Peter G. M.D., Joseph J. M.D., Linda Ph.D., Beryl L. M.D.,